Airway Smooth Muscles Contractions in Metabolic Syndrome. 2022

Yu G Birulina, and V V Ivanov, and E E Buiko, and A N Dzyuman, and A V Nosarev, and O V Voronkova, and M O Vol'khina, and S V Gusakova
Siberian State Medical University, Ministry of Health of the Russian Federation, Tomsk, Russia. birulina20@yandex.ru.

We studied contractile responses of isolated airway smooth muscle segments from rats with metabolic syndrome. Metabolic syndrome was induced in rats by high-fat and high-carbohydrate diet. It was shown that metabolic syndrome was associated with an increase of bronchoconstrictor action of cholinergic receptor activator carbacholine (0.1-100 μM) and a decrease of the dilatory effect of β2-adrenoreceptor activator salbutamol (0.1-100 μM). The observed effects of agonists are epithelium-dependent. Disorders in contractile activity in the airway smooth muscles were accompanied by bronchial epithelium destruction, immune inflammation in the bronchial wall, muscular and peribronchial adipose tissue hypertrophy.

UI MeSH Term Description Entries
D009119 Muscle Contraction A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. Inotropism,Muscular Contraction,Contraction, Muscle,Contraction, Muscular,Contractions, Muscle,Contractions, Muscular,Inotropisms,Muscle Contractions,Muscular Contractions
D009130 Muscle, Smooth Unstriated and unstriped muscle, one of the muscles of the internal organs, blood vessels, hair follicles, etc. Contractile elements are elongated, usually spindle-shaped cells with centrally located nuclei. Smooth muscle fibers are bound together into sheets or bundles by reticular fibers and frequently elastic nets are also abundant. (From Stedman, 25th ed) Muscle, Involuntary,Smooth Muscle,Involuntary Muscle,Involuntary Muscles,Muscles, Involuntary,Muscles, Smooth,Smooth Muscles
D011950 Receptors, Cholinergic Cell surface proteins that bind acetylcholine with high affinity and trigger intracellular changes influencing the behavior of cells. Cholinergic receptors are divided into two major classes, muscarinic and nicotinic, based originally on their affinity for nicotine and muscarine. Each group is further subdivided based on pharmacology, location, mode of action, and/or molecular biology. ACh Receptor,Acetylcholine Receptor,Acetylcholine Receptors,Cholinergic Receptor,Cholinergic Receptors,Cholinoceptive Sites,Cholinoceptor,Cholinoceptors,Receptors, Acetylcholine,ACh Receptors,Receptors, ACh,Receptor, ACh,Receptor, Acetylcholine,Receptor, Cholinergic,Sites, Cholinoceptive
D001980 Bronchi The larger air passages of the lungs arising from the terminal bifurcation of the TRACHEA. They include the largest two primary bronchi which branch out into secondary bronchi, and tertiary bronchi which extend into BRONCHIOLES and PULMONARY ALVEOLI. Primary Bronchi,Primary Bronchus,Secondary Bronchi,Secondary Bronchus,Tertiary Bronchi,Tertiary Bronchus,Bronchi, Primary,Bronchi, Secondary,Bronchi, Tertiary,Bronchus,Bronchus, Primary,Bronchus, Secondary,Bronchus, Tertiary
D002217 Carbachol A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS. Carbamylcholine,Carbacholine,Carbamann,Carbamoylcholine,Carbastat,Carbocholine,Carboptic,Doryl,Isopto Carbachol,Jestryl,Miostat,Carbachol, Isopto
D002241 Carbohydrates A class of organic compounds composed of carbon, hydrogen, and oxygen in a ratio of Cn(H2O)n. The largest class of organic compounds, including STARCH; GLYCOGEN; CELLULOSE; POLYSACCHARIDES; and simple MONOSACCHARIDES. Carbohydrate
D000420 Albuterol A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. Salbutamol,2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol,Albuterol Sulfate,Proventil,Sultanol,Ventolin
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D016085 Bronchoconstrictor Agents Agents causing the narrowing of the lumen of a bronchus or bronchiole. Bronchial-Constricting Agents,Bronchoconstrictor Effect,Bronchoconstrictor Effects,Bronchoconstrictors,Agents, Bronchial-Constricting,Agents, Bronchoconstrictor,Bronchial Constricting Agents,Effect, Bronchoconstrictor,Effects, Bronchoconstrictor
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Yu G Birulina, and V V Ivanov, and E E Buiko, and A N Dzyuman, and A V Nosarev, and O V Voronkova, and M O Vol'khina, and S V Gusakova
April 2000, Pathophysiology : the official journal of the International Society for Pathophysiology,
Yu G Birulina, and V V Ivanov, and E E Buiko, and A N Dzyuman, and A V Nosarev, and O V Voronkova, and M O Vol'khina, and S V Gusakova
August 1977, Canadian journal of physiology and pharmacology,
Yu G Birulina, and V V Ivanov, and E E Buiko, and A N Dzyuman, and A V Nosarev, and O V Voronkova, and M O Vol'khina, and S V Gusakova
March 1962, Journal of applied physiology,
Yu G Birulina, and V V Ivanov, and E E Buiko, and A N Dzyuman, and A V Nosarev, and O V Voronkova, and M O Vol'khina, and S V Gusakova
January 1981, Pharmacology,
Yu G Birulina, and V V Ivanov, and E E Buiko, and A N Dzyuman, and A V Nosarev, and O V Voronkova, and M O Vol'khina, and S V Gusakova
March 1976, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Yu G Birulina, and V V Ivanov, and E E Buiko, and A N Dzyuman, and A V Nosarev, and O V Voronkova, and M O Vol'khina, and S V Gusakova
August 2003, The American journal of medicine,
Yu G Birulina, and V V Ivanov, and E E Buiko, and A N Dzyuman, and A V Nosarev, and O V Voronkova, and M O Vol'khina, and S V Gusakova
August 1991, European journal of pharmacology,
Yu G Birulina, and V V Ivanov, and E E Buiko, and A N Dzyuman, and A V Nosarev, and O V Voronkova, and M O Vol'khina, and S V Gusakova
July 1993, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
Yu G Birulina, and V V Ivanov, and E E Buiko, and A N Dzyuman, and A V Nosarev, and O V Voronkova, and M O Vol'khina, and S V Gusakova
April 1979, Agents and actions,
Yu G Birulina, and V V Ivanov, and E E Buiko, and A N Dzyuman, and A V Nosarev, and O V Voronkova, and M O Vol'khina, and S V Gusakova
April 1978, Comprehensive therapy,
Copied contents to your clipboard!